title: A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.
abstract: We compared the effects of ibandronate and pamindronate in patients with bone metastases from breast or lung cancer and we found that ibandronate is superior to pamindronate in alleviating pain, improving mobility and quality of life, and reducing bone resorption indices in patients with bone metastases from breast or lung cancer.
authors.affiliation: General Hospital of Nafplio, Department of Internal Medicine, Nafplio, Greece. panheras@yahoo.com
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Heras
authors.forename: Antonios
authors.initials: A
authors.lastname: Hatzopoulos
authors.forename: Vasilios
authors.initials: V
authors.lastname: Heras
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Kritikos
authors.forename: Stefanos
authors.initials: S
authors.lastname: Karagiannis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Kritikos
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001862:Bone Resorption / Q000188:drug therapy / Q000209:etiology; D001943:Breast Neoplasms / Q000150:complications; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D000077268:Pamidronate; D011788:Quality of Life
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate; D000077557:Ibandronic Acid